Final Call 🚨
Submissions close tomorrow for JCF’s Focus Issue on Innovations in Heart Transplantation.
If your research offers new insight into transplantation techniques, outcomes, or care models, don’t miss the deadline 👉 April 10, 2026
#CallForPapers #HeartTransplantation #Cardiology
One week remains to submit to JCF’s Focus Issue on Innovations in Heart Transplantation. ⌛
We’re seeking research that advances transplantation strategies, outcomes, and clinical decision-making.
🗓️ Deadline: April 10, 2026
#CallForPapers #HeartTransplantation #Cardiology
📣 Two weeks remain to submit to JCF’s Focus Issue on Innovations in Heart Transplantation.
Now is the time to share research shaping what comes next.
🗓️ Deadline: April 10, 2026
#CallForPapers #HeartTransplantation #Cardiology
Heart transplantation is entering a new era — shaped by innovation, data, and clinical insight.
JCF invites submissions for a dedicated Focus Issue on Innovations in Heart Transplantation.
📅 Deadline: April 10, 2026.
#CallForPapers #HeartTransplantation #Cardiology
Call for Papers 🚨
Focus Issue: Innovations in Heart Transplantation
JCF’s upcoming focus issue will examine the breakthroughs reshaping heart transplantation today.
Submit your research by April 10, 2026.
#CallForPapers #HeartTransplantation #Cardiology
The next chapter of heart transplantation is being written now. Submit to JCF’s Focus Issue on Innovations in Heart Transplantation. 🫀
Submissions due by April 10, 2026.
#CallForPapers #HeartTransplantation #Cardiology
📢 A NEW #ISHLT Consensus Statement on clinical cardiac #xenotransplantation is now available. 📖💡🫀 This document lays out the scientific, clinical, and regulatory blueprint to move pig-to-human #hearttransplantation from possibility to disciplined progress.
Read the publication at 🔗 bit.ly/4s1gecC
From evolving transplant techniques to post-transplant management and outcomes, JCF’s upcoming Focus Issue will explore Innovations in Heart Transplantation.
📄 Submit your research by April 10, 2026.
#CallForPapers #HeartTransplantation #Cardiology
📣 JCF is now accepting submissions for a Focus Issue dedicated to Innovations in Heart Transplantation, highlighting advances across clinical practice, research, and patient outcomes.
🗓️ Deadline to submit: April 10, 2026
#CallForPapers #HeartTransplantation #Cardiology
Routine CAC monitoring could thus become a useful tool in optimizing long-term outcomes after heart transplantation." - Sonja Jankovic
#HeartTransplantation #CoronaryCalcium #CardiovascularRisk
buff.ly/VhX7OKT (Simran P. Sharma et al.)
Join ISHLT's #AHFTX #InterdisciplinaryNetwork
next week for a discussion on emerging practices, outcomes, & ethical considerations surrounding the use of #NRP in #DCD #HeartTransplantation. 🫀
➡️ Register: 🔗 https://bit.ly/497CXNr
#TransplantSky #MedSky
#ISHLT members, join the #AHFTX #InterdisciplinaryNetwork for a webinar exploring emerging practices, outcomes, and ethical considerations on the use of #NRP in #DCD #HeartTransplantation. 🫀
📅 13 Jan | 2:00 p.m. ET
➡️ View the program + register: https://bit.ly/497CXNr
Next month on #ISHLTv, the #AHFTX #InterdisciplinaryNetwork will host a webinar exploring emerging practices, outcomes, & ethical considerations on the use of #NRP in #DCD #HeartTransplantation. 🫀
▶️ Learn more and register at 🔗 https://bit.ly/497CXNr
#TransplantSky #MedSky
In last month's #ISHLTJournalWatch, #KatharinaFetten reviews a study on the association of agonal phase duration with heart utilization & post-transplant outcomes in #DCD #HeartTransplantation. 🫀
#ISHLT #CardiogenicShock #TransplantSky
In the second study for #ISHLTJournalWatch last month, #RamDuvuru reviews a 5-year study on the outcomes of #DCD #HeartTransplantation. 🫀
#ISHLT #CardiogenicShock #TransplantSky
Antibody-independent microvascular inflammation impacts long-term risk in heart transplantation
Amancherla, K., Bearl, D. W. et al.
Paper
Details
#HeartTransplantation #MicrovascularInflammation #AntibodyIndependentImmunity
Have you checked out the latest #ISHLT Standards + Guidelines? 🔎📖Two recently published documents cover:
❤️ Antibodies and #AMR in #HeartTransplantation
🤔 Postoperative considerations on the perioperative use of #ECLS in #LungTransplantation
View these + more at 🔗 https://bit.ly/45YUzbq
Check out this #ISHLTVoices podcast episode, presented by #Natera, on the evolution of dd-cfDNA testing and noninvasive rejection monitoring post-heart transplantation. ❤️
🎧 LISTEN NOW at 🔗 bit.ly/4lnW9K2, Spotify, Apple Podcasts 🎧
#HeartTransplantation #ddcfDNA #ProsperaHeart #DQS
New insights into cold ischemia–reperfusion injury after heart transplant: Lysine β-hydroxybutyrylation (Kbhb)–modified proteins are altered post-I/R and enriched in pathways tied to contraction and metabolism. #HeartTransplantation #TXPforAll tinyurl.com/3ynn535h
Hear ye, Hear ye! Our PREHAB RCT failed, Read all about it.
🔗: www.cjcopen.ca/article/S258...
#hearttransplantation #HIIT #PREHAB #heartfailure #cardiacrehabilitation
🧵 (1-8) 👇
Specific EV cargo profiling (proteins + miRNAs) from donor hearts & T cells enables noninvasive detection of moderate acute cellular rejection (ACR) after #hearttransplantation. @PrashanthVall12 #TXPforAll #biomarker tinyurl.com/yp5j34ke
Change of Personality Quiz Questions
Click here for answers
1. #hearttransplantation #kidneytransplantation #PubQuizzes #QuizQuestionsandAnswers #thedavincicode #TriviaQuizQuestions #TriviaQuizQuestionsandAnswers #triviaquizzes
go4quiz.com/change-of-pe...
Preparing the future of organ banking in #HeartTransplantation. - The Journal of Heart and Lung Transplantation www.jhltonline.org/article/S105...
New article to read! Heart transplant recipients with diabetes who used SGLT2 inhibitors had a significantly lower risk of dialysis, graft rejection, and mortality compared to non-users.
🔗 doi.org/10.1111/joim.20077
#SGLT2 #hearttransplantation #dialysis
Heart failure (HF) remains a critical public health issue, with heart transplantation (HT) as the definitive treatment for end-stage HF. #BridgetoTransplant #CardiacSurgery #HeartFailureOutcomes #HeartTransplantation #LVAD #MechanicalCirculatorySupport
bit.ly/42jqxPu
#OnThisDay in 1996 the late Princess Diana officially opened our temporary premises in Darlinghurst. Since then, our #scientists have made world-first breakthroughs in #HeartTransplantation, #HeartAttack risk identification, and #CHD, among many more:
victorchang.edu.au/heart-research…